AN OPEN LABEL, REGISTRY STUDY OF THE SAFETY OF ILUVIEN 190 MICROGRAMS INTRAVITREAL IMPLANT IN APPLICATOR
Phase of Trial: Phase IV
Latest Information Update: 01 Jun 2016
At a glance
- Drugs Fluocinolone acetonide (Primary)
- Indications Diabetic macular oedema
- Focus Adverse reactions
- Sponsors Alimera Sciences
- 23 May 2016 Interim results (n=292) published in an Alimera Sciences media release.
- 23 May 2016 Interim data (n=292) presented at the 2016 Royal College of Ophthalmologists (RCOpth) Annual Congress, according to an Alimera Sciences media release.
- 24 Jun 2014 New trial record